<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f1 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f2 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f3 { font-family:serif; font-weight:normal; font-style:normal; }
#f4 { font-family:serif; font-weight:normal; font-style:italic; }
#f5 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f6 { font-family:serif; font-weight:bold; font-style:normal; }
#f7 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f8 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f9 { font-family:sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body onload="start()">
<img id="background" style="position:absolute; left:0px; top:0px;" width="556" height="790" src="page1027.png">
<div class="txt" style="position:absolute; left:144px; top:86px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">ART. VI—PRIOR DEBTS, SUPREMACY CLAUSE, ETC. 1001</span></div>
<div class="txt" style="position:absolute; left:217px; top:113px;"><span id="f6" style="font-size:7px;vertical-align:baseline;color:#231f1f;">Cl. 2—Supremacy of the Constitution, Laws, and Treaties</span></div>
<div class="txt" style="position:absolute; left:142px; top:130px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">compliance. In </span><span id="f4" style="font-size:9px;vertical-align:baseline;color:#231f1f;">Pliva, Inc. v. Mensing</span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">,</span><span id="f3" style="font-size:5px;vertical-align:super;color:#231f1f;">61 </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">federal law required ge-</span></div>
<div class="txt" style="position:absolute; left:142px; top:142px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">neric drugs to be labeled the same as the brand name counterpart,</span></div>
<div class="txt" style="position:absolute; left:142px; top:155px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">while state tort law required drug labels to contain adequate warn-</span></div>
<div class="txt" style="position:absolute; left:142px; top:167px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">ings to render use of the drug reasonably safe. There had been ac-</span></div>
<div class="txt" style="position:absolute; left:142px; top:179px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">cumulating evidence that long-term use of the drug metoclopramide</span></div>
<div class="txt" style="position:absolute; left:142px; top:192px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">carried a signiﬁcant risk of severe neurological damage, but manu-</span></div>
<div class="txt" style="position:absolute; left:142px; top:204px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">facturers of generic metoclopramide neither amended their warn-</span></div>
<div class="txt" style="position:absolute; left:142px; top:216px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">ing labels nor sought to have the Food and Drug Administration</span></div>
<div class="txt" style="position:absolute; left:142px; top:229px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">require the brand name manufacturer to include stronger label warn-</span></div>
<div class="txt" style="position:absolute; left:142px; top:241px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">ings, which consequently would have led to stronger labeling of the</span></div>
<div class="txt" style="position:absolute; left:142px; top:254px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">generic. Five Justices held that state tort law was preempted.</span><span id="f3" style="font-size:5px;vertical-align:super;color:#231f1f;">62 </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">It</span></div>
<div class="txt" style="position:absolute; left:142px; top:266px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">was impossible to comply both with the state law duty to change</span></div>
<div class="txt" style="position:absolute; left:142px; top:278px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">the label and the federal law duty to keep the label the same.</span><span id="f3" style="font-size:5px;vertical-align:super;color:#231f1f;">63</span></div>
<div class="txt" style="position:absolute; left:142px; top:291px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">The four dissenting Justices argued that inability to change the la-</span></div>
<div class="txt" style="position:absolute; left:142px; top:303px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">bels unilaterally was insufficient, standing alone, to establish a de-</span></div>
<div class="txt" style="position:absolute; left:142px; top:315px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">fense based on impossibility.</span><span id="f3" style="font-size:5px;vertical-align:super;color:#231f1f;">64 </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">Emphasizing the federal duty to moni-</span></div>
<div class="txt" style="position:absolute; left:142px; top:328px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">tor the safety of their drugs, the dissenters would require that the</span></div>
<div class="txt" style="position:absolute; left:142px; top:340px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">generic manufacturers also show some effort to effectuate a label-</span></div>
<div class="txt" style="position:absolute; left:142px; top:352px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">ing change through the FDA.</span></div>
<div class="txt" style="position:absolute; left:160px; top:370px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">In contrast to </span><span id="f4" style="font-size:9px;vertical-align:baseline;color:#231f1f;">Pliva, Inc. v. Mensing</span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">, the Court found no preemp-</span></div>
<div class="txt" style="position:absolute; left:142px; top:382px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">tion in </span><span id="f4" style="font-size:9px;vertical-align:baseline;color:#231f1f;">Wyeth v. Levine</span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">,</span><span id="f3" style="font-size:5px;vertical-align:super;color:#231f1f;">65 </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">a state tort action against a brand-name</span></div>
<div class="txt" style="position:absolute; left:142px; top:395px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">drug manufacturer based on inadequate labeling. A brand-name drug</span></div>
<div class="txt" style="position:absolute; left:142px; top:407px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">manufacturer, unlike makers of generic drugs, could unilaterally</span></div>
<div class="txt" style="position:absolute; left:142px; top:419px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">strengthen labeling under federal regulations, subject to subse-</span></div>
<div class="txt" style="position:absolute; left:142px; top:431px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">quent FDA override, and thereby independently meet state tort law</span></div>
<div class="txt" style="position:absolute; left:142px; top:444px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">requirements. In another case of alleged impossibility, it was held</span></div>
<div class="txt" style="position:absolute; left:142px; top:456px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">possible for an employer to comply both with a state law mandat-</span></div>
<div class="txt" style="position:absolute; left:142px; top:468px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">ing leave and reinstatement to pregnant employees and with a fed-</span></div>
<div class="txt" style="position:absolute; left:142px; top:480px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">eral law prohibiting employment discrimination on the basis of preg-</span></div>
<div class="txt" style="position:absolute; left:142px; top:493px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">nancy.</span><span id="f3" style="font-size:5px;vertical-align:super;color:#231f1f;">66 </span><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">Similarly, when faced with both federal and state standards</span></div>
<div class="txt" style="position:absolute; left:142px; top:505px;"><span id="f3" style="font-size:9px;vertical-align:baseline;color:#231f1f;">on the ripeness of avocados, the Court discerned that the federal</span></div>
<div class="txt" style="position:absolute; left:158px; top:535px;"><span id="f3" style="font-size:4px;vertical-align:super;color:#231f1f;">61 </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">564 U.S. ___, No. 09–993, slip op. (2011).</span></div>
<div class="txt" style="position:absolute; left:158px; top:544px;"><span id="f3" style="font-size:4px;vertical-align:super;color:#231f1f;">62 </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">564 U.S. ___, No. 09–993, slip op. (2011) (Thomas, J.).</span></div>
<div class="txt" style="position:absolute; left:158px; top:553px;"><span id="f3" style="font-size:4px;vertical-align:super;color:#231f1f;">63 </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">Justice Thomas, joined on point by three others, characterized the Su-</span></div>
<div class="txt" style="position:absolute; left:142px; top:562px;"><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">premacy Clause phrase “any [state law] to the Contrary notwithstanding” as a </span><span id="f4" style="font-size:7px;vertical-align:baseline;color:#231f1f;">non</span></div>
<div class="txt" style="position:absolute; left:142px; top:571px;"><span id="f4" style="font-size:7px;vertical-align:baseline;color:#231f1f;">obtstante </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">provision that “suggests that federal law should be understood to impliedly</span></div>
<div class="txt" style="position:absolute; left:142px; top:580px;"><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">repeal conﬂicting state law” and indicates limits on the extent to which courts should</span></div>
<div class="txt" style="position:absolute; left:142px; top:589px;"><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">seek to reconcile federal and state law in preemption cases. 564 U.S. ___, No. 09–</span></div>
<div class="txt" style="position:absolute; left:142px; top:598px;"><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">993, slip op. at 15–17 (2011) (Thomas, J.).</span></div>
<div class="txt" style="position:absolute; left:158px; top:607px;"><span id="f3" style="font-size:4px;vertical-align:super;color:#231f1f;">64 </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">564 U.S. ___, No. 09–993, slip op. (2011) (Sotomayor, J., dissenting).</span></div>
<div class="txt" style="position:absolute; left:158px; top:616px;"><span id="f3" style="font-size:4px;vertical-align:super;color:#231f1f;">65 </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">555 U.S. ___, No. 06–1249, slip op. (2009).</span></div>
<div class="txt" style="position:absolute; left:158px; top:625px;"><span id="f3" style="font-size:4px;vertical-align:super;color:#231f1f;">66 </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">California Federal Savings &amp; Loan Ass’n v. Guerra, 479 U.S. 272 (1987). </span><span id="f4" style="font-size:7px;vertical-align:baseline;color:#231f1f;">Com-</span></div>
<div class="txt" style="position:absolute; left:142px; top:634px;"><span id="f4" style="font-size:7px;vertical-align:baseline;color:#231f1f;">pare </span><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">Cloverleaf Butter Co. v. Patterson, 315 U.S. 148 (1942) (federal law preempts</span></div>
<div class="txt" style="position:absolute; left:142px; top:643px;"><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">more exacting state standards, even though both could be complied with and state</span></div>
<div class="txt" style="position:absolute; left:142px; top:652px;"><span id="f3" style="font-size:7px;vertical-align:baseline;color:#231f1f;">standards were harmonious with purposes of federal law).</span></div>
</body>
</html>
